Literature DB >> 22123059

Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media.

Timothy Kaschak1, Daniel Boyd, Franklin Lu, Gayle Derfus, Brian Kluck, Bartek Nogal, Craig Emery, Christie Summers, Kai Zheng, Robert Bayer, Ashraf Amanullah, Boxu Yan.   

Abstract

We report a case study of an IgG1 with a unique basic charge variant profile caused by C-terminal proline amidation on either one or two heavy chains. The proline amidation was sensitive to copper ion concentration in the production media during cell culture: the higher the Cu ( 2+) ion concentration, the higher the level of proline amidation detected. This conclusion was supported by the analysis of samples that revealed direct correlation between the proline amidation level observed from peptide maps and the level of basic peaks measured by imaged capillary isoelectric focusing and a pH gradient ion-exchange chromatography method. The importance of these observations to therapeutic antibody production is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123059      PMCID: PMC3242844          DOI: 10.4161/mabs.3.6.17959

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  27 in total

1.  Identification of multiple sources of charge heterogeneity in a recombinant antibody.

Authors:  R J Harris; B Kabakoff; F D Macchi; F J Shen; M Kwong; J D Andya; S J Shire; N Bjork; K Totpal; A B Chen
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-10

Review 2.  New insights into copper monooxygenases and peptide amidation: structure, mechanism and function.

Authors:  S T Prigge; R E Mains; B A Eipper; L M Amzel
Journal:  Cell Mol Life Sci       Date:  2000-08       Impact factor: 9.261

Review 3.  Peptide amidation.

Authors:  A F Bradbury; D G Smyth
Journal:  Trends Biochem Sci       Date:  1991-03       Impact factor: 13.807

4.  Characterizing biological products and assessing comparability following manufacturing changes.

Authors:  Arthur J Chirino; Anthony Mire-Sluis
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

5.  In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.

Authors:  Lihua Huang; Jirong Lu; Victor J Wroblewski; John M Beals; Ralph M Riggin
Journal:  Anal Chem       Date:  2005-03-01       Impact factor: 6.986

6.  Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.

Authors:  A Wright; S L Morrison
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

7.  Characterization of a peptide alpha-amidation activity in human plasma and tissues.

Authors:  G S Wand; R L Ney; S Baylin; B Eipper; R E Mains
Journal:  Metabolism       Date:  1985-11       Impact factor: 8.694

8.  Characterization of peptide alpha-amidation activity in human cerebrospinal fluid and central nervous system tissue.

Authors:  G S Wand; R L Ney; R E Mains; B A Eipper
Journal:  Neuroendocrinology       Date:  1985-12       Impact factor: 4.914

9.  Expression and characterization of human bifunctional peptidylglycine alpha-amidating monooxygenase.

Authors:  Manabu Satani; Kenichi Takahashi; Hiroshi Sakamoto; Saori Harada; Yasuhiko Kaida; Masato Noguchi
Journal:  Protein Expr Purif       Date:  2003-04       Impact factor: 1.650

Review 10.  Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture.

Authors:  R J Harris
Journal:  J Chromatogr A       Date:  1995-06-23       Impact factor: 4.759

View more
  18 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 2.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

Review 3.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 4.  In vitro and in vivo modifications of recombinant and human IgG antibodies.

Authors:  Hongcheng Liu; Gomathinayagam Ponniah; Hui-Min Zhang; Christine Nowak; Alyssa Neill; Nidia Gonzalez-Lopez; Rekha Patel; Guilong Cheng; Adriana Z Kita; Bruce Andrien
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

Review 5.  Micro-Heterogeneity of Antibody Molecules.

Authors:  Yusuke Mimura; Radka Saldova; Yuka Mimura-Kimura; Pauline M Rudd; Roy Jefferis
Journal:  Exp Suppl       Date:  2021

6.  Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media.

Authors:  Jianlin Xu; Matthew S Rehmann; Xuankuo Xu; Chao Huang; Jun Tian; Nan-Xin Qian; Zheng Jian Li
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

7.  Secretion of Fc-amidated peptide fusion proteins by Chinese hamster ovary cells.

Authors:  Kristina R Carlson; Steven C Pomerantz; Jiali Li; Omid Vafa; Michael Naso; William Strohl; Richard E Mains; Betty A Eipper
Journal:  BMC Biotechnol       Date:  2015-06-27       Impact factor: 2.563

8.  Optimizing production of Fc-amidated peptides by Chinese hamster ovary cells.

Authors:  Kristina Carlson; Steven C Pomerantz; Omid Vafa; Michael Naso; William Strohl; Richard E Mains; Betty A Eipper
Journal:  BMC Biotechnol       Date:  2015-10-16       Impact factor: 2.563

9.  Reduction in C-terminal amidated species of recombinant monoclonal antibodies by genetic modification of CHO cells.

Authors:  Mihaela Škulj; Dejan Pezdirec; Dominik Gaser; Marko Kreft; Robert Zorec
Journal:  BMC Biotechnol       Date:  2014-08-14       Impact factor: 2.563

10.  Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.

Authors:  Yan-Yan Zhao; Ning Wang; Wan-Hui Liu; Wen-Jie Tao; Li-Li Liu; Zhen-Duo Shen
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.